Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Scientific Reports|October 5, 2017
Associations between SNPs and immune-related circulating proteins in schizophreniaMan K Chan, Jason D Cooper, Stefanie Heilmann-Heimbach, et al.
The International Journal of Neuropsychopharmacology|June 6, 2014
Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patientsViktoria Stelzhammer, Frieder Haenisch, Man K Chan, et al.
AIDS Research and Therapy|September 30, 2021
Early ART-initiation and longer ART duration reduces HIV-1 proviral DNA levels in children from the CHER trialHelen Payne, Man K Chan, Sarah A Watters, et al.
Journal of Psychiatric Research|October 4, 2016
Blood-based immune-endocrine biomarkers of treatment response in depressionMan K Chan, Jason D Cooper, Mariska Bot, et al.
AIDS (London, England)|May 6, 2025
Assessment of the steady-state drug-drug interactions between dolutegravir and ritonavir-boosted darunavir in adolescentsSeef Abdalla, Alexandra Compagnucci, Alasdair Bamford, et al.
Molecular and Cellular Neurosciences|April 1, 2009
Prolyl oligopeptidase binds to GAP-43 and functions without its peptidase activityElena Di Daniel, Colin P Glover, Emma Grot, et al.
Plos One|March 2, 2013
Structure of the arginine methyltransferase PRMT5-MEP50 reveals a mechanism for substrate specificityMeng-Chiao Ho, Carola Wilczek, Jeffrey B Bonanno, et al.
Journal of Proteome Research|April 30, 2009
Antipsychotic treatment alters protein expression associated with presynaptic function and nervous system development in rat frontal cortexDan Ma, Man K Chan, Helen E Lockstone, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2023
Simultaneous pharmacokinetic modeling of unbound and total darunavir with ritonavir in adolescents: a substudy of the SMILE trialSeef Abdalla, Alexandra Compagnucci, Yoann Riault, et al.
The Lancet. HIV|February 21, 2022
Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trialHylke Waalewijn, Man K Chan, Pauline D J Bollen, et al.
Pageof 3